First CBD Purchase: How to Choose the Product, Dose, and Form (oil, flower, gummies) in 2026

The first purchase of CBD seems to be a choice between percentages on the label, but in practice, it is a choice between forms of administration and between sellers who show batch test results and those who do not. The market gives reason for caution: in an analysis of 84 CBD extracts purchased online, only 26 products, or 31 percent of the sample, had label-compliant content. This guide walks you through six decisions you make before clicking the cart: why you are buying, in what form, at what concentration, with what extract profile, with what batch certificate, and at what price per milligram. Separately, it shows what science still does not know about absorption and safe dosing, as this is the other half of the picture that guides usually overlook.

KEY INFORMATION
- The certificate of analysis for a specific batch is the only verifiable element of the offer; without it, the product's content remains a seller's declaration.
- A systematic review of CBD pharmacokinetics in humans provides absolute bioavailability only for one route of administration: 31 percent after smoking (Millar 2018). For sublingual drops and capsules, it has not been established at all.
- In 2026, EFSA derived a provisional safe dose of 0.0275 mg per kilogram of body weight per day, which is about 2 mg daily for a person weighing 70 kg (EFSA 2026).
- The safety of CBD cannot be established today for individuals under 25 years of age, pregnant and breastfeeding women, and those taking medications.
- Compare products by price per milligram, not by package price; only this number shows how much you are actually buying.

Where to start your first CBD purchase?

Start with two decisions: why you are buying and how you want to use the product daily. Concentration, brand, and price are consequences of these answers, not starting points. Someone looking for evening relaxation will buy a different product than someone who wants something for a trip, even if both have the same percentage on the label.

The reason is practical. Forms of administration differ primarily in how much effort they require from the user and how easily the same dose can be repeated. Drops allow you to measure a dose down to the drop, but require a ritual with a pipette and getting used to the taste. Gummies are a ready-made dose without measuring, but without the possibility of dividing it. Flower requires equipment and a place where it is allowed to be used.

The second thing to determine before purchasing is the horizon. A product bought for one evening and a product bought for two months of daily use are two different calculations, including financial ones. For a single trial, the lowest entry cost matters; for continuous use, the price per milligram and whether the seller will keep the same product in stock are important.

The third thing is honesty about your own expectations. Published studies on cannabidiol concern narrow, well-defined situations and specific doses given in a laboratory. None of them indicate what will happen after purchasing an online bottle with unknown content. Therefore, treat your first purchase as buying a product with a specific composition, not as buying a promised effect. If you are looking for help with a specific health issue, talking to a doctor is the first step, not the last.

A good complement to this decision is our the guide to types of CBD oils, which breaks down the differences between carriers and flavor versions.

What are the differences between oil, flower, gummies, capsules, and cosmetics?

They differ in the route of administration, and therefore in the method of use, repeatability of doses, and required equipment. Drops reach the mucous membrane of the mouth and partially into the digestive tract, gummies and capsules only into the digestive tract, flower into the lungs, and cosmetics remain on the skin. This distinction organizes the entire selection.

Oil is the most flexible form. A 10 ml bottle contains about 200 drops, so the dose can be gradually adjusted rather than in jumps. However, you must remember to hold the drops under your tongue for several seconds and accept the plant taste, which flavor versions do not completely eliminate.

Gummies and capsules are purchased for convenience and repeatability. The manufacturer has measured the dose for you, nothing needs to be counted or held under the tongue. The price is the lack of flexibility: gummies cannot be divided in a controlled manner, and capsules cannot be divided at all. Capsules have the advantage over gummies in that they do not contain sugar or dyes.

Hemp flower requires a vaporizer and a place where it can be used. It is the least discreet form due to the smell. Smoking flower, whether in a joint or a pipe, carries the same risks as smoking tobacco and is not a method of use that could be recommended. Cosmetics work locally and do not replace oral forms; they are purchased for a specific area on the skin, not for systemic purposes.

Ile CBD z dawki trafia do krwiobiegu?

The honest answer is: for most forms, no one has measured this in humans. A systematic review of the pharmacokinetics of cannabidiol in humans included 792 identified works, of which 24 provided pharmacokinetic parameters, and reported absolute bioavailability exclusively for one route of administration, smoking, at a level of 31 percent (Millar 2018).

The authors stated explicitly that no other study attempted to determine absolute bioavailability after other routes of administration, even though intravenous forms are available that would allow this. This is important information for the buyer, as popular tables comparing the absorption percentage of drops, capsules, and gummies have no basis in this review. The numbers circulating in guides are usually copied from other guides.

What the review really established is the half-life and concentration profile over time. After oral mucosal spray, the half-life ranged from 1.4 to 10.9 hours, after chronic oral administration from 2 to 5 days, after intravenous administration 24 hours, and after smoking 31 hours. The maximum concentration appeared between zero and four hours after administration and increased with the dose.

One practical tip from this work is well documented: the maximum concentration increases after a meal and in fat-based forms. Therefore, manufacturers use oil as a carrier, and taking an oral product with food containing fat makes sense. The rest of the promises about significantly better absorption, including nanoemulsion marketing, go beyond what the review confirms.

Eight years later, the same conclusion was reiterated by the food safety assessment body. In the EFSA position update from 2026, it was stated that pharmacokinetic studies confirmed the variable bioavailability of cannabidiol, dependent on the carrier matrix and food intake (EFSA 2026). Variability is therefore a described property of this substance today, not a gap that a better product would fill. For the buyer, this means one thing: treat promises regarding absorption percentages as marketing material, not as a technical parameter.

What concentration of oil should you choose to start?

The percentage on the label does not indicate the strength of action, only the density of cannabidiol in the carrier. It directly translates to how many milligrams one drop carries, and thus how precisely the dose can be measured and how long the bottle will last. Low concentration provides precision, high provides convenience and lower unit cost.

The arithmetic is simple and worth doing yourself with each offer. A 10 ml bottle contains about 200 drops. At a concentration of 5 percent, it contains 500 mg of cannabidiol, which is about 2.5 mg per drop. At 10 percent, that's 1000 mg and about 5 mg per drop; at 20 percent, 2000 mg and about 10 mg. Manufacturers report the number of drops differently, as it depends on the viscosity of the carrier and the design of the pipette, so treat it as an approximation.

For the first purchase, the technical argument speaks, not the health one: with a lower concentration, the same change of one drop is a smaller change, making it easier to observe what happens. High-concentration bottles make sense for someone who already knows their reaction and wants to limit the number of drops, not for someone who is just starting.

Do not transfer this arithmetic to the conclusion about the daily dose. How many milligrams to take is a question of safety, not of the label, and a separate section below returns to it. You can find more about the concentrations themselves in our comparison of oils at 5, 10, 20, and 30 percent.

Broad spectrum, full spectrum, or isolate?

These three words describe what remains in the extract besides cannabidiol. Isolate is pure cannabidiol. Broad spectrum retains other cannabinoids and terpenes but removes tetrahydrocannabinol. Full spectrum leaves the complete plant profile, including trace amounts of tetrahydrocannabinol.

The argument used to sell full-spectrum products is the so-called entourage effect. Its most frequently cited work is Ethan Russo's review in the British Journal of Pharmacology from 2011, dedicated to cannabis terpenes and their possible cooperation with cannabinoids (Russo 2011). It is worth reading how the author formulates the conclusion: he writes about synergy that still requires proof and proposes methods to investigate it in future experiments.

In other words, the entourage effect is a well-justified hypothesis, not a measured quantity. No one has determined how much stronger one preparation would be compared to another with the same cannabidiol content, and no such number stands in the literature. If a guide gives you such a multiplier, it has copied it from advertising.

The review itself has a strong observational basis. Russo reminds us that cannabis terpenoids are potent compounds that affect the behavior of animals and even humans at blood concentrations of single nanograms per milliliter, achieved even after inhalation from the environment. This is a good argument for knowing the terpene profile in general, and at the same time no argument for a specific product efficacy multiplier.

For the buyer, however, the practical difference is significant. A full-spectrum product contains trace amounts of tetrahydrocannabinol, so for someone undergoing drug testing, broad spectrum or isolate are safer choices. The Polish threshold for hemp is calculated as the sum of delta-9-THC and tetrahydrocannabinolic acid, not just delta-9-THC itself, and this value should be shown on the batch certificate. The differences between the extracts themselves break down our zestawienie destylatu i izolatu.

How to read the certificate of analysis?

The certificate of analysis, abbreviated as COA, is the result of laboratory testing for a specific batch of the product. It is the only element of the offer that can be independently verified, regardless of what the seller writes. The reason why this verification makes sense is measured and published.

In a study published in JAMA in 2017, 84 CBD extracts purchased online were analyzed. 26 products had contents consistent with the label, meaning within 10 percent of the declaration, which is 30.95 percent of the sample. In 36 products (42.85 percent), there was more cannabidiol than on the label, and in 22 (26.19 percent), less. Tetrahydrocannabinol was detected in 18 of the 84 samples, or 21.43 percent (Bonn-Miller i wsp., JAMA 2017).

Note the distribution of these errors. The most frequently mislabelled were vaping liquids, among which 21 products deviated from the label, while the most accurately labelled were oils, where 18 out of 40 studied items were compliant. This distinction is important for the first purchase, as it indicates in which category the manufacturer's declaration was statistically most reliable.

Read the certificate element by element, not by the overall impression. Check the laboratory name and its accreditation, the batch number matching the packaging, the testing date, the cannabinoid profile with tetrahydrocannabinol separately listed, and contamination tests: pesticides, heavy metals, microbiology, and solvent residues. A certificate without a batch number or issued by the manufacturer's laboratory does not serve its purpose, as it cannot be assigned to the bottle you are holding.

It's also important to know what the certificate does not clarify. The legal threshold of 0.3 percent refers to the plant material, meaning the sum of delta-9-THC and tetrahydrocannabinolic acid in the flowering or fruiting tops of the plant calculated on a dry weight basis, not to the finished product. The product certificate indicates the content in milligrams per milliliter or per gram, and these two values are not the same measurement. If the seller refers to the plant threshold when describing the finished oil, they are confusing two different levels of regulation.

How to calculate if the purchase is worth it?

Divide the price of the packaging by the total cannabidiol content in milligrams. This single operation organizes the comparison of offers better than anything else, as packaging varies in volume, concentration, and number of units, while the price on the page does not reflect these differences. A more expensive bottle can be cheaper when calculated per milligram.

An example of a calculation without referring to a specific offer: a 10 ml oil with a concentration of 5 percent contains 500 mg, while an oil of the same volume and a concentration of 10 percent contains 1000 mg. If the more expensive one costs less than twice as much as the cheaper one, it is more advantageous when calculated per milligram, even though it appears more expensive on the page. For gummies, multiply the number of units by the declared content of one unit and only then divide the price.

Do not compare categories as if a milligram meant the same everywhere. As shown in the pharmacokinetics section, for most routes of administration, it is unknown what portion of the dose reaches the bloodstream, so calculating the price per absorbed milligram would be counting on an immeasurable coefficient. The declared price per milligram is a fair measure, while the price per absorbed milligram is a made-up measure.

The following ranges show the order of magnitudes in our store as of August 10, 2026, so you have a reference point when reading others' offers. The prices of individual products change faster than the article, so always check the current amount on the category page.

What mistakes are commonly repeated during the first purchase?

The most common mistake is buying based on the percentage on the label without checking how many milligrams are in the packaging and whether the batch has a test result. The second is comparing packaging prices instead of prices per milligram. Both are reversible mistakes and both cost you only because they come to light after the purchase.

The third mistake is subtler: buying a form that does not fit the day. Drops require space and a moment of calm, gummies are discreet, and flower requires equipment. A product that is inconvenient to use ends up in a drawer, and then it doesn't matter how good its test result was.

The fourth is relying on the seller's reasoning instead of on documentation. If the product description contains health claims, it is a warning sign in itself, as health claims for cannabidiol have not been authorized in the European Union. A seller who offers a story about effects instead of a batch certificate is telling you what is missing.

The fifth and most costly mistake is skipping a conversation with a doctor or pharmacist if you are taking any medications. This is not a formality added at the end of guides; it returns to a separate section on interactions. The summary below organizes all five.

Co wiadomo o bezpiecznej dawce CBD?

The most recent answer comes from the 2026 update of the EFSA position on the safety of cannabidiol as a novel food. The panel derived a provisional safe dose of 0.0275 mg per kilogram of body weight per day using the benchmark dose method, with an uncertainty factor of 400, which is about 2 mg daily for a person weighing 70 kg (EFSA 2026).

This value has a clearly defined range. It applies only to supplements with a purity of cannabidiol of at least 98 percent, without nanoparticles, produced through a safe process, and excluding genotoxicity. It does not apply to other forms or products with unknown compositions, which means most of what is purchased online without a batch certificate.

The panel also indicated what it does not know. The safety of cannabidiol cannot be established today for individuals under 25 years of age, for pregnant and breastfeeding women, and for those taking medications simultaneously. The gaps identified in 2022 have not been closed, as new studies have methodological limitations: non-standardized protocols, short duration, and accompanying treatments.

For clarity, it is worth knowing what doses were studied in anxiety experiments, as they are sometimes cited in guides as suggestions for readers. In a study with simulated public speaking, 57 healthy men received a single dose of 150 mg, 300 mg, 600 mg of cannabidiol, or a placebo; anxiety during the speech was reduced only by the 300 mg dose, while the larger dose had no effect (Linares i wsp. 2019). This describes a single laboratory experiment, not a guideline for buyers.

Where does the gap between those hundreds of milligrams and the two milligrams from the EFSA assessment come from? From the uncertainty factor of 400, which the panel divided the reference point derived from sub-chronic studies compliant with good laboratory practice. Such a large factor measures how much remains unknown in this matter, rather than the harmfulness of the substance. The panel also noted gastrointestinal effects at higher doses and insufficient data on neurological and psychiatric safety.

Who should consult CBD with a doctor?

Anyone taking prescription medications, who is pregnant or breastfeeding, is under 25 years old, or has liver disease. This is not a precautionary list added at the end, but a reflection of what experts evaluating cannabidiol have written. Two groups of reasons stand behind this recommendation.

The first is interactions. In an in vitro study on the inhibition of liver cytochrome P450 enzymes by cannabinoids and their metabolites, it was shown that cannabidiol competitively inhibits CYP3A4, CYP2B6, CYP2C9, CYP2D6, and CYP2E1, while acting on CYP1A2 in a mixed manner (Nasrin i wsp. 2021). These same enzymes are responsible for the metabolism of many medications, so simultaneous use can alter their concentration in the blood.

The second is the liver. In the EFSA assessment, animal studies showed consistent liver toxicity, with liver mass and histopathological changes as sensitive endpoints, while human studies indicated a potential hepatotoxicity, especially with the simultaneous use of other medications. The panel also noted the transfer of cannabidiol across the placenta and hormonal disturbances, including altered thyroid hormone levels.

The practical conclusion is brief. If you are taking anything on prescription, discussing it with a doctor or pharmacist should be part of the pre-purchase stage, not after. The time gap between taking a medication and consuming a product with cannabidiol does not solve this problem, as enzyme inhibition lasts longer than the presence of the substance in the digestive tract.

Two additional findings from the same assessment are worth knowing before making a purchase. After prenatal exposure, long-term neurodevelopmental effects were observed, which are gender-dependent, and this is another reason why the product is not recommended during pregnancy. Immunotoxicity, on the other hand, has not been studied at all: no work addressed this endpoint, despite the fact that cannabidiol interacts with immune system pathways. The lack of a study is not the same as a negative result.

Is CBD legal in Poland?

Cannabidiol itself does not appear on any lists of controlled substances, and products from industrial hemp are legally traded in Poland. The decisive factor is the raw material and the content of tetrahydrocannabinol in the plant material from which the product was made, not the product's trade name.

The definition of industrial hemp states that the total content of delta-9-THC and tetrahydrocannabinolic acid in the flowering or fruiting tops of plants, from which the resin has not been removed, does not exceed 0.3 percent when calculated on a dry weight basis, with the total rounded to one decimal place. The basis is Article 4 point 5 of the Act of July 29, 2005 on Counteracting Drug Addiction (t.j. Dz.U. 2023 poz. 1939), as amended the Act of March 24, 2022 (Dz.U. 2022 poz. 763)..

Two things are worth separating here. The national threshold corresponds to the EU threshold, but it does not follow from it: the EU's 0.3 percent for varieties eligible for support under the Common Agricultural Policy was introduced by Regulation 2021/2115, applicable from January 1, 2023, while the previous EU threshold was 0.2 percent. These are two separate regulations with the same numerical value.

A separate issue is the food status. Cannabidiol remains subject to the novel food procedure in the European Union, and a health notification is not an authorization, while the EFSA position from 2026 is a safety assessment with conditions, not a market approval for food. Therefore, products are sold in categories other than dietary supplements, and descriptions cannot contain health claims.

Separate regulations apply to food from hemp seeds and are expressed in milligrams per kilogram, not in percentages. The maximum allowable level is 3.0 mg/kg for hemp seeds and for ground seeds and other products processed from them, and 7.5 mg/kg for hemp seed oil. The level refers to the sum of delta-9-THC and delta-9-THCA expressed as delta-9-THC, with a factor of 0.877 for the acid. The basis is Annex I to Commission Regulation (EU) 2023/915 on the maximum allowable levels of certain contaminants in food, applicable from May 25, 2023.

Frequently Asked Questions

Does the concentration of the oil indicate its potency?

No. The percentage on the label describes the density of cannabidiol in the carrier, not the strength of the effect. It translates to how many milligrams are in one drop: at 5 percent, it is about 2.5 mg, at 10 percent about 5 mg. A higher concentration means fewer drops, not a stronger product.

Which form of CBD is absorbed best?

For most forms, no one has measured this in humans. A systematic review of pharmacokinetics provides absolute bioavailability only after smoking, at 31 percent, and notes that for other routes of administration, no study has established this. Tables comparing absorption percentages of drops and capsules have no basis in this review.

How to recognize a reliable certificate of analysis?

By the fact that it can be assigned to your packaging. It must include the name and accreditation of the laboratory, a batch number consistent with the packaging, the date of testing, a cannabinoid profile with tetrahydrocannabinol listed separately, and contamination tests. A document without a batch number or issued by the manufacturer's laboratory does not fulfill its function.

How to compare the prices of two CBD oils?

Divide the price of the packaging by the total number of milligrams of cannabidiol it contains. A 10 ml bottle with a concentration of 5 percent has 500 mg, while one with a concentration of 10 percent has 1000 mg. If the stronger one costs less than twice as much as the weaker one, it is more favorable when calculated per milligram.

What is the difference between broad spectrum and isolate?

Isolate contains only high-purity cannabidiol, while broad spectrum retains other cannabinoids and terpenes, but without tetrahydrocannabinol. The advantage of the full profile, known as the entourage effect, remains a hypothesis requiring proof, so no number describing the difference in potency between them is supported by the literature.

How much CBD can be safely taken?

In 2026, EFSA derived a provisional safe dose of 0.0275 mg per kilogram of body weight per day, which is about 2 mg daily for a person weighing 70 kg. This applies only to supplements with a purity of at least 98 percent without nanoparticles. For other forms, this value has not been established.

Does CBD interact with medications?

Yes. In vitro studies showed that cannabidiol competitively inhibited the enzymes CYP3A4, CYP2B6, CYP2C9, CYP2D6, and CYP2E1, which are responsible for the metabolism of many drugs. EFSA also stated that the safety of cannabidiol cannot be established in individuals taking medications. A conversation with a doctor precedes the purchase.

Is CBD legal in Poland?

Yes, as long as the product comes from industrial hemp. The law defines them by the sum of delta-9-THC and tetrahydrocannabinolic acid not exceeding 0.3 percent of dry mass, rounded to one decimal place. Cannabidiol itself does not appear on controlled substance lists, but it is also not authorized as a novel food.

Lista kontrolna przed pierwszym zakupem

Go through these points one by one before choosing a specific product. Each of them concerns something that can be checked before payment, not something you will find out after a month. The order is not random: it starts with questions about you and ends with questions about documents.

1. Determine how you want to use the product on a typical day and how much time you have for it.
2. Choose the form according to this rhythm, not based on the promise in the description.
3. Decide on the extract profile; when testing for the presence of psychoactive substances, avoid versions with trace amounts of tetrahydrocannabinol.
4. Count the milligrams in the entire package and divide the price by that.
5. Request a certificate of analysis for the batch number on the packaging.
6. Check the certificate for the content of cannabidiol, tetrahydrocannabinol, and contamination studies.
7. If you are taking any medications, consult your purchase with a doctor or pharmacist.
8. Record what you bought and when, so that when making the next purchase, you can compare data, not impressions.

A broader overview of what can be purchased and what to pay attention to in descriptions can be found in our text about naturalnych suplementach CBD w Polsce.

You can check current prices and the composition of individual products in the category oils.

This article is for informational and educational purposes and does not constitute medical advice. Before starting to use cannabis or CBD for therapeutic purposes, consult a doctor, especially if you are taking other medications, are pregnant, or breastfeeding.

Author: Michał Waluk · Opublikowano: 2026-05-11 · Aktualizacja: 2026-08-10